Ledger.Open graph →
SEC Form D · Amendment · filed April 23, 2021

Revelation Biosciences, Inc

Offering
$4.4M
Sold
$4.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jess F. Roper · San Diego, CADirectorChester S. Zygmont Iii · San Diego, CAExecJennifer F. Carver · San Diego, CADirectorJames M. Rolke · San Diego, CAExec · DirectorGeorge F. Tidmarsh · San Diego, CADirectorCurt F. Labelle · San Diego, CADirectorDoonaye Sookye · Morc St Andre, O4DirectorDavid Welch · Oakland, CAExec · DirectorNavus Capital Management LP · Oakland, CADirectorRajiv Seetul · Beau Bassin, O4ExecRajan Lukose · Oakland, CADirectorJulian N. Fletcher · Grand Cayman, Cayman IslandsDirectorIrene Egset · Oslo, Q8ExecGrethe Moen · Oslo, Q8DirectorJan Schoolmeesters · Oslo, Q8DirectorSven Borre Larsen · Oslo, Q8Exec · DirectorChristopher Finlayson · Oslo, Q8DirectorMatt Blodgett · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗